Literature DB >> 22044397

Modulation of glucokinase by glucose, small-molecule activator and glucokinase regulatory protein: steady-state kinetic and cell-based analysis.

Francis J Bourbonais1, Jing Chen, Cong Huang, Yanwei Zhang, Jeffrey A Pfefferkorn, James A Landro.   

Abstract

GK (glucokinase) is an enzyme central to glucose metabolism that displays positive co-operativity to substrate glucose. Small-molecule GKAs (GK activators) modulate GK catalytic activity and glucose affinity and are currently being pursued as a treatment for Type 2 diabetes. GK progress curves monitoring product formation are linear up to 1 mM glucose, but biphasic at 5 mM, with the transition from the lower initial velocity to the higher steady-state velocity being described by the rate constant kact. In the presence of a liver-specific GKA (compound A), progress curves at 1 mM glucose are similar to those at 5 mM, reflecting activation of GK by compound A. We show that GKRP (GK regulatory protein) is a slow tight-binding inhibitor of GK. Analysis of progress curves indicate that this inhibition is time dependent, with apparent initial and final Ki values being 113 and 12.8 nM respectively. When GK is pre-incubated with glucose and compound A, the inhibition observed by GKRP is time dependent, but independent of GKRP concentration, reflecting the GKA-controlled transition between closed and open GK conformations. These data are supported by cell-based imaging data from primary rat hepatocytes. This work characterizes the modulation of GK by a novel GKA that may enable the design of new and improved GKAs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22044397     DOI: 10.1042/BJ20110721

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  5 in total

Review 1.  Glucokinase regulatory protein: complexity at the crossroads of triglyceride and glucose metabolism.

Authors:  Anne Raimondo; Matthew G Rees; Anna L Gloyn
Journal:  Curr Opin Lipidol       Date:  2015-04       Impact factor: 4.776

2.  Antidiabetic Action of Mcy Protein: Studies on Gene Expression and Competitive Binding to Insulin Receptors.

Authors:  Saritha Marella; Peddanna Kotha; S Abdul Nabi; B P Girish; Kameswara Rao Badri; Apparao Chippada
Journal:  Appl Biochem Biotechnol       Date:  2022-04-08       Impact factor: 3.094

3.  Chronic glucokinase activator treatment at clinically translatable exposures gives durable glucose lowering in two animal models of type 2 diabetes.

Authors:  D J Baker; G P Wilkinson; A M Atkinson; H B Jones; M Coghlan; A D Charles; B Leighton
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

4.  Analysis of the co-operative interaction between the allosterically regulated proteins GK and GKRP using tryptophan fluorescence.

Authors:  Bogumil Zelent; Anne Raimondo; Amy Barrett; Carol W Buettger; Pan Chen; Anna L Gloyn; Franz M Matschinsky
Journal:  Biochem J       Date:  2014-05-01       Impact factor: 3.857

5.  A panel of diverse assays to interrogate the interaction between glucokinase and glucokinase regulatory protein, two vital proteins in human disease.

Authors:  Matthew G Rees; Mindy I Davis; Min Shen; Steve Titus; Anne Raimondo; Amy Barrett; Anna L Gloyn; Francis S Collins; Anton Simeonov
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.